A Study of Fisetin to Treat Carpal Tunnel Syndrome

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 9, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Carpal Tunnel Syndrome

Interventions

DRUG

Fisetin

100 mg capsules orally for 2 consecutive days and, after 1 month, another 2 consecutive days

Trial Locations (1)

Mayo Clinic in Rochester, Rochester

All Listed Sponsors

lead

Peter C. Amadio, M.D.

OTHER